Patents Assigned to ASCEPION PHARMACEUTICALS, INC.
  • 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
    Patent number: 8648086
    Abstract: The present invention provides 5,6-bicyclic heteroaryl-containing urea compounds of Formula I or II and use of the same for treating conditions mediated by protein kinase such as VEGFR2, c-Met, PDGFR? c-Kit, CSF1R, or EphA2.
    Type: Grant
    Filed: August 20, 2010
    Date of Patent: February 11, 2014
    Assignee: Ascepion Pharmaceuticals, Inc.
    Inventors: Shan Jiang, Xinglong Xing, Qishan Wang, Ren Kong
  • DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS
    Publication number: 20130165475
    Abstract: The present invention provides deuterium-enriched heteroaryl-containing urea compounds (I) and use of the same for treating conditions mediated by protein kinase such as
    Type: Application
    Filed: September 1, 2011
    Publication date: June 27, 2013
    Applicant: ASCEPION PHARMACEUTICALS, INC.
    Inventors: Shan Jiang, Qishan Wang, Xiaoyong Gao